The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 07, 2025

Filed:

Nov. 21, 2022
Applicant:

Medtronic Cryocath Lp, Toronto, CA;

Inventor:

Boaz Avitall, Chicago, IL (US);

Assignee:

Medtronic CryoCath LP, Toronto, CA;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61B 5/00 (2006.01); A61B 5/01 (2006.01); A61B 5/053 (2021.01); A61B 5/0536 (2021.01); A61B 5/0538 (2021.01); A61B 5/283 (2021.01); A61B 5/287 (2021.01); A61B 18/02 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
A61B 5/01 (2013.01); A61B 5/053 (2013.01); A61B 5/0536 (2013.01); A61B 5/0538 (2013.01); A61B 5/283 (2021.01); A61B 5/287 (2021.01); A61B 5/6853 (2013.01); A61B 18/02 (2013.01); A61B 2018/00351 (2013.01); A61B 2018/00357 (2013.01); A61B 2018/00375 (2013.01); A61B 2018/00642 (2013.01); A61B 2018/00791 (2013.01); A61B 2018/00797 (2013.01); A61B 2018/00839 (2013.01); A61B 2018/00863 (2013.01); A61B 2018/00875 (2013.01); A61B 2018/0212 (2013.01); A61B 2018/0262 (2013.01); A61B 2505/05 (2013.01); A61B 2562/046 (2013.01);
Abstract

A device, system, and method for treating an area of tissue and evaluating lesion formation and quality. The system may include a medical device having a plurality of mapping electrodes on a treatment element, the plurality of mapping electrodes being configured to record from the area of tissue at least one of unipolar impedance measurements, bipolar impedance measurements, local electrical activity, and pace threshold measurements before, during, and after circulation of the cryogenic fluid within the treatment element. These measurements may be transmitted to a control unit having processing circuitry configured to compare pre-treatment measurements, in-treatment measurements, and/or post-treatment measurements to each other and/or to threshold values to determine occlusion and/or lesion quality, such as lesion transmurality.


Find Patent Forward Citations

Loading…